Company Snapshot: IMNX  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Immunex Chief Executive Officer to Present at the Chase H&Q 19th Annual Healthcare Conference

    SEATTLE, Jan. 9 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX)
announced today that Ed Fritzky, Immunex chairman, chief executive officer and
president, will present at the 19th Annual Chase H&Q Healthcare Conference at
8:00 a.m. PST on Wednesday, January 10, 2001.  The conference is being held at
the Westin St. Francis Hotel in San Francisco, California.  The presentation
will be web cast live for investors and available for replay at
http://www.chasehq.com/events/index.html.
    Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.

    NOTE:  This news release contains forward-looking statements that involve
risks and uncertainties, including risks associated with clinical development,
regulatory approvals, our reliance on third-party manufacturers, product
commercialization and other risks described from time to time in the SEC
reports filed by Immunex, including the most recently filed Form 10-Q.  An
electronic version of this news release -- as well as additional information
about Immunex of interest to investors, customers, future employees and
patients -- is available on the Immunex home page at http://www.immunex.com.


SOURCE Immunex Corporation




Back to Topback to top

Related links:
  • http://www.immunex.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/434644.html or fax,
    800-758-5804, ext. 434644
    CONTACT:
    media, Kris Greco, 206-470-4871, or
    investors, Mark Leahy, 206-389-4363, both of Immunex Corporation